Meningococcal vaccination: several vaccines are available to children and adults

Provide the pros and cons for one of the solutions you are proposing.
January 7, 2019
Discuss the findings of the articles. Would you apply the evidence found to your practice?
January 7, 2019

15–20 PowerPoint slides

Use at least 30 point font size consistently throughout 

10 REFERENCES

Choose a PowerPoint design, color scheme, font type, and bullet types

  • ·

Organize the slides based on your headings and subheadings

· Include a title slide (at the beginning) and a reference slide (at the end of the presentation)

Do not overload the slides with text and data

Use bullet points to organize your text

Keep the text abbreviated and concise

Choose a different layout for each slide

Use pictures, graphics, charts, and graphs to illustrate key points

Graphics should make a key concept clearer

Final slides should emphasize key points or leave the audience with a question to think about or answer

I. Definition

II. Cause of the disease

Need to know

a. Overview: Some people are at a high risk of contracting meningococcal disease. The risks involve travel, age, community setting, and certain medical conditions (Ghebrehewet, Conrad & Marsh, (2016).

b. Meningococcal vaccination: several vaccines are available to children and adults

I. Transmission: The disease is causes by Neisseria Meningitides. It is classified as airborne disease because it is transmitted through kissing or coughing.

· Signs & symptoms: The disease present the signs and symptoms of flu-illness, and can have additional signs such as fever, headache, nausea, vomiting, altered mental status, among others (Tsang & Taha, 2016)

· Prevention: Vaccines and antibiotics appear to be the most effective (Pollard, Feavers & Cohn, 2016).

· Meningococcal conjugate vaccine (MCV4)

9 months to 55 years Menactra

2 years old to 55 years old Menveo

· Meningococcal polysaccharide vaccine (MPSV4)

· Serogroup B Meningococcal B

 

I. Treatment: Treatment is mainly based on the use of antibiotics (Nadel & Carcillo, 2016)

II. Conclusion

References

Brandtzaeg, P. (2006). Pathogenesis and Pathophysiology of Invasive Meningococcal Disease. Handbook of Meningococcal Disease, 427-480. doi:10.1002/3527608508.ch21

Ghebrehewet, S., Conrad, D., & Marsh, G. (2016). Meningitis and meningococcal disease. Oxford Medicine Online. doi:10.1093/med/9780198745471.003.0011

Nadel, S., & Carcillo, J. (2016). Treatment of meningococcal disease. Handbook of Meningococcal Disease Management, 75-90. doi:10.1007/978-3-319-28119-3_6

Pollard, A. J., Feavers, I., & Cohn, A. (2016). Prevention of meningococcal disease through vaccination. Handbook of Meningococcal Disease Management, 91-103. doi:10.1007/978-3-319-28119-3_7

Tsang, R., & Taha, M. (2016). Diagnosis of meningococcal disease. Handbook of Meningococcal Disease Management, 45-55. doi:10.1007/978-3-319-28119-3_4

 

"Are you looking for this answer? We can Help click Order Now"

UK BEST WRITING